What symptoms are reported by patients with hypermobile Ehlers‑Danlos syndrome who exhibit reduced orthostatic cerebral blood‑flow velocity and small‑fiber neuropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms in hEDS Patients with Reduced Orthostatic Cerebral Blood Flow Velocity and Small Fiber Neuropathy

Patients with hypermobile Ehlers-Danlos syndrome who exhibit reduced orthostatic cerebral blood flow velocity and small fiber neuropathy report a constellation of orthostatic, pain, autonomic, and gastrointestinal symptoms, with orthostatic dizziness being the most directly correlated with cerebrovascular dysregulation.

Orthostatic and Cerebrovascular Symptoms

  • Orthostatic dizziness is the hallmark symptom directly correlated with reduced orthostatic cerebral blood flow velocity, which occurs in 79% of hEDS patients 1
  • Lightheadedness upon standing is a primary manifestation of cerebral hypoperfusion 2
  • Blurred vision occurs as a consequence of inadequate cerebral perfusion during postural changes 2
  • Generalized weakness accompanies orthostatic intolerance in this population 2
  • Palpitations and tremulousness are common autonomic manifestations 2

Pain and Sensory Symptoms

  • Neuropathic pain is nearly universal, with all but one patient in studied cohorts reporting pain consistent with small fiber neuropathy 3
  • Pain intensity ranges from moderate (NRS ≥4) to severe (NRS ≥7), with the majority experiencing severe pain 3
  • Patients report 7 or more symptoms on the Small Fiber Neuropathy Symptoms Inventory Questionnaire 3
  • Both proximal and distal body regions are affected, reflecting the generalized distribution of nerve fiber loss rather than a typical length-dependent pattern 4
  • Thermal and tactile hypesthesia (reduced sensation) occurs throughout the body 4
  • Chronic widespread pain is a defining feature, present in over 90% of patients 1

Autonomic Dysfunction Symptoms

  • Widespread but mild autonomic failure is present in 90% of hEDS patients 1
  • Orthostatic sudomotor symptoms (abnormal sweating patterns with position changes) occur in over 90% 1
  • Vasomotor symptoms (abnormal blood vessel responses) affect over 90% of patients 1
  • Cognitive dysfunction accompanies autonomic dysregulation 2
  • Bladder dysfunction is not uncommon in this population 2

Gastrointestinal Symptoms

  • Gastrointestinal symptoms occur in over 90% of hEDS patients and are more severe in those with concomitant POTS 1, 2
  • Nausea is one of the most predictive symptoms of abnormal GI motility 2
  • Abdominal pain is highly prevalent and predictive of dysmotility 2
  • Early satiety frequently occurs 2
  • Vomiting, diarrhea, bloating, and severe constipation are common manifestations 2
  • These symptoms may be attributable to visceral hypersensitivity and/or dysmotility 2

Specific Orthostatic Syndromes Identified

The head-up tilt testing in this population reveals distinct patterns:

  • Postural tachycardia syndrome (POTS) occurs in 33% of hEDS patients with these features 1
  • Hypocapnic cerebral hypoperfusion is present in 22% 1
  • Orthostatic cerebral hypoperfusion syndrome affects 18% 1
  • Neurogenic orthostatic hypotension occurs in 9% 1

Important Clinical Considerations

The combination of reduced orthostatic cerebral blood flow velocity and small fiber neuropathy creates a dual mechanism for symptom generation: cerebrovascular dysregulation causes orthostatic symptoms while small fiber neuropathy contributes to pain, sensory disturbances, and autonomic dysfunction 1, 4. The small fiber neuropathy in hEDS is generalized rather than length-dependent, explaining why patients report symptoms in both proximal and distal body regions 4. This differs from typical diabetic or other metabolic neuropathies that follow a stocking-glove distribution.

Patients with dysautonomia show both A-delta and C-fiber impairment, while those without dysautonomia may only exhibit A-delta fiber loss 5. This suggests a spectrum of small fiber involvement that correlates with the severity of autonomic symptoms.

The prevalence of small fiber neuropathy using combined structural and functional criteria reaches 82% in hEDS patients 1, making it an extremely common feature that contributes substantially to the symptom burden alongside cerebrovascular dysregulation.

Related Questions

Do approximately 90 % of individuals with hypermobile Ehlers‑Danlos syndrome exhibit mild, widespread autonomic dysfunction, and what are the recommended screening and first‑line non‑pharmacologic treatments?
In a patient with hypermobile Ehlers‑Danlos syndrome who regularly does strength training with a personal trainer, brisk walks, light yoga, and physical‑therapy, should a beta‑adrenergic blocker be added to manage fatigue and orthostatic tachycardia?
A 29-year-old woman with a 4-year history of near-daily fever, fatigue, low complement C3 and C4, nonspecific antinuclear antibody positivity, hypermobile Ehlers-Danlos syndrome, and ADHD—what is the most likely diagnosis and what work‑up and initial treatment should be pursued?
What laboratory tests are recommended for a patient with hypermobile Ehlers-Danlos Syndrome (hEDS)?
In a patient with hypermobile Ehlers‑Danlos syndrome, borderline POTS, chronic low‑grade fever, Raynaud‑type vasospasm, low complement and a high‑titer (1:1280) fine‑speckled ANA with negative anti‑double‑stranded DNA, what does this result indicate and what further work‑up and management should be pursued?
Can you help me prepare a medical slide presentation?
Can aspirin (Ecospirin (acetylsalicylic acid) 75 mg) be started after surgical hemostasis for secondary stroke prevention while the patient remains on enoxaparin (Clexane (enoxaparin) 40 mg daily) for postoperative DVT prophylaxis?
What are the common neonatal skin lesions?
What are the physiological effects and potential complications of arteriovenous (AV) shunts?
In a 63‑year‑old woman with a large fungating breast mass, severe hypercalcemia, acute renal failure, hyponatremia, hypokalemia, orthostatic hypotension, and confusion who has already received aggressive isotonic IV fluids, what is the next best step: measure parathyroid hormone‑related protein, administer zoledronic acid, measure receptor activator of nuclear factor‑κB ligand, or initiate hemodialysis?
When should a patient with hypertension be referred to cardiology?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.